|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Avalo Therapeutics, Inc (AVTX) |
|
|
$0.43 0.00 (0.00%) as of 4:30 Thu 7/7
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
112,320,000 |
Market
Cap: |
48.31(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.4301 - $0.4301 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Avalo Therapeutics is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology and rare genetic diseases. Co.'s clinical-stage pipeline include: AVTX-002, which is developing for the treatment of non-eosinophilic asthma, inflammatory bowel disease; AVTX-007, which is developing AVTX-007 for the treatment of Still's Disease; AVTX-801, which is a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency; and AVTX-803, which is a L-fucose substrate replacement therapy for the treatment of LADII.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
1,000 |
1,000 |
Total Buy Value |
$0 |
$0 |
$12,750 |
$12,750 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2025-04-03 |
2024-12-31 |
2024-07-02 |
2023-07-03 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Neil Garry Arthur |
Chief Executive Officer |
|
2025-03-28 |
4 |
D |
$8.46 |
$150,478 |
D/D |
(17,787) |
47,140 |
|
- |
|
Neil Garry Arthur |
Chief Executive Officer |
|
2025-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
64,867 |
64,927 |
|
- |
|
Truex Samantha |
Director |
|
2025-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,167 |
3,167 |
|
- |
|
Kantoff Aaron |
Director |
|
2025-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,167 |
3,167 |
|
- |
|
Chan Mitchell |
Director |
|
2025-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,167 |
3,167 |
|
- |
|
Almenoff June Sherie |
Director |
|
2025-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,167 |
3,167 |
|
- |
|
Sullivan Christopher Ryan |
Chief Financial Officer |
|
2025-03-28 |
4 |
D |
$8.46 |
$61,631 |
D/D |
(7,285) |
16,921 |
|
- |
|
Sullivan Christopher Ryan |
Chief Financial Officer |
|
2025-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,200 |
24,206 |
|
- |
|
Goldman Jonathan |
Director |
|
2025-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,167 |
3,167 |
|
- |
|
Kaplan Gilla Phd |
Director |
|
2025-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,167 |
3,167 |
|
- |
|
Almenoff June Sherie |
Director |
|
2024-11-13 |
4 |
B |
$13.00 |
$6,500 |
I/I |
500 |
1,000 |
2.1 |
- |
|
Almenoff June Sherie |
Director |
|
2024-11-12 |
4 |
B |
$12.50 |
$6,250 |
I/I |
500 |
500 |
2.1 |
- |
|
Boyd Steven |
10% Owner |
|
2023-06-27 |
4 |
S |
$0.52 |
$486,888 |
I/I |
(937,404) |
731,458 |
|
- |
|
Boyd Steven |
10% Owner |
|
2023-06-26 |
4 |
S |
$0.61 |
$1,682,010 |
I/I |
(2,746,138) |
1,668,862 |
|
- |
|
Caissa Capital Management Ltd. |
10% Owner |
|
2023-06-26 |
4 |
S |
$0.62 |
$113,026 |
D/D |
(182,300) |
0 |
|
- |
|
Caissa Capital Management Ltd. |
10% Owner |
|
2023-06-26 |
4 |
S |
$0.64 |
$917,153 |
I/I |
(1,425,700) |
0 |
|
- |
|
Caissa Capital Management Ltd. |
10% Owner |
|
2023-06-14 |
4 |
B |
$3.48 |
$20,874 |
I/I |
6,000 |
1,417,540 |
1.5 |
- |
|
Caissa Capital Management Ltd. |
10% Owner |
|
2023-06-13 |
4 |
B |
$3.82 |
$33,439 |
I/I |
8,750 |
1,411,540 |
1.5 |
- |
|
Caissa Capital Management Ltd. |
10% Owner |
|
2023-06-12 |
4 |
B |
$4.34 |
$9,316 |
I/I |
2,149 |
1,402,790 |
1.5 |
- |
|
Sullivan Christopher Ryan |
Chief Financial Officer |
|
2023-06-09 |
4 |
B |
$3.42 |
$1,748 |
D/D |
511 |
1,262 |
2.66 |
- |
|
Neil Garry Arthur |
CEO and Chairman of the Board |
|
2023-06-09 |
4 |
B |
$3.42 |
$13,680 |
D/D |
4,000 |
13,220 |
2.81 |
- |
|
Caissa Capital Management Ltd. |
10% Owner |
|
2023-06-09 |
4 |
B |
$4.14 |
$20,896 |
I/I |
5,044 |
1,400,641 |
1.5 |
- |
|
Caissa Capital Management Ltd. |
10% Owner |
|
2023-06-08 |
4 |
B |
$3.93 |
$25,126 |
I/I |
6,398 |
1,395,597 |
1.5 |
- |
|
Caissa Capital Management Ltd. |
10% Owner |
|
2023-06-07 |
4 |
B |
$3.49 |
$10,418 |
I/I |
2,984 |
1,389,199 |
1.5 |
- |
|
Caissa Capital Management Ltd. |
10% Owner |
|
2023-05-31 |
4 |
B |
$2.87 |
$2,422 |
I/I |
844 |
1,386,215 |
1.42 |
- |
|
452 Records found
|
|
Page 1 of 19 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|